Department of Veterans Affairs Contract Awards FY2021
Fiscal Years:FY2025
Total Awarded$71.0B
Contracts52,617
Top ContractorTRIWEST HEALTHCARE ALLIANCE CORP
Department of Veterans Affairs (VA) awarded $71.0B across 52,617
federal contracts in FY2021. ▲ 388.5% vs FY2020
The largest single contractor was TRIWEST HEALTHCARE ALLIANCE CORP.
ℹ️ FY2021 = Oct 2020 – Sep 2021 (U.S. federal fiscal year) |
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Top Contractors
| Company | Share | Total | Contracts |
|---|---|---|---|
| TRIWEST HEALTHCARE ALLIANCE CORP | $33658.3M | 22건 | |
| OPTUM PUBLIC SECTOR SOLUTIONS, INC. | $8908.6M | 7건 | |
| MCKESSON CORPORATION | $7342.3M | 14건 | |
| QTC MEDICAL SERVICES INC | $873.8M | 5건 | |
| ORACLE HEALTH GOVERNMENT SERVICES, INC. | $825.7M | 9건 | |
| BOOZ ALLEN HAMILTON INC | $643.0M | 5건 | |
| INCYTE CORPORATION | $557.2M | 8건 | |
| VETERANS EVALUATION SERVICES, INC | $475.2M | 6건 | |
| OPTUMSERVE HEALTH SERVICES, INC. | $410.7M | 4건 | |
| ACCENTURE FEDERAL SERVICES LLC | $368.8M | 1건 |
Notable Awards
| Date | Recipient | Amount | Description |
|---|---|---|---|
| 2021-04-01 | TRIWEST HEALTHCARE ALLIANCE CORP | $26903.9M | COMMUNITY CARE NETWORK REGION 4 – OPTION YEAR 2 TASK ORDER FUNDING OPTION YEAR 2 |
| 2021-04-01 | TRIWEST HEALTHCARE ALLIANCE CORP | $3602.8M | EXPRESS REPORT: FY 21 |
| 2020-10-01 | OPTUM PUBLIC SECTOR SOLUTIONS, INC. | $3088.9M | CCN REGION THREE FY21 EXPRESS REPORT |
| 2020-10-01 | OPTUM PUBLIC SECTOR SOLUTIONS, INC. | $2907.9M | EXPRESS REPORT: FY21 |
| 2020-10-01 | OPTUM PUBLIC SECTOR SOLUTIONS, INC. | $2747.1M | EXPRESS REPORT FOR FY 21 REGION 1 |
| 2021-01-01 | TRIWEST HEALTHCARE ALLIANCE CORP | $1402.9M | EXPRESS REPORT FOR 2QTR FY2021 UNDER PC3 CONTRACT |
| 2020-10-01 | TRIWEST HEALTHCARE ALLIANCE CORP | $1153.4M | EXPRESS REPORT FOR SERVICES FOR THE PATIENT CENTERED COMMUNITY CARE (PC3) CONTRA |
| 2021-09-01 | MCKESSON CORPORATION | $775.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 SEPTEMBER |
| 2021-08-01 | MCKESSON CORPORATION | $681.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 AUGUST |
| 2021-03-01 | MCKESSON CORPORATION | $658.3M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 MARCH |
| 2021-06-01 | MCKESSON CORPORATION | $654.8M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 JUNE |
| 2021-07-01 | MCKESSON CORPORATION | $638.8M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 JULY |
| 2021-04-01 | MCKESSON CORPORATION | $618.7M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 APRIL |
| 2020-10-01 | MCKESSON CORPORATION | $585.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 OCTOBER |
| 2020-12-01 | MCKESSON CORPORATION | $584.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 DECEMBER |
| 2021-05-01 | MCKESSON CORPORATION | $575.5M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 MAY |
| 2021-01-01 | MCKESSON CORPORATION | $557.7M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 JANUARY |
| 2020-11-04 | INCYTE CORPORATION | $557.0M | PEMAZYRE 9MG TAB |
| 2021-02-01 | MCKESSON CORPORATION | $520.4M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 FEBRUARY |
| 2020-11-01 | MCKESSON CORPORATION | $490.9M | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2021 NOVEMBER |